Both in Pharmaceuticals
Lipocine vs Cellectar Biosciences INC NEW
Over the past year LPCN returned −43.1% and CLRB returned −63.3%; their daily moves had a correlation of 0.06.
LPCN −43.1% CLRB −63.3%Growth of $1, one year, split-adjusted
| Metric | LPCN | CLRB |
|---|---|---|
| Price | $1.44 | $1.23 |
| Market cap | $11.9M | $11.6M |
| Today | −1.37% | −6.11% |
| 1 month | −31.4% | −18.5% |
| 6 months | −40.7% | −65.2% |
| Year to date | −82.1% | −58.3% |
| 1 year | −45.7% | −62.7% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 9.4× | — |
| Net cash | $23.3M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 68.7% |
| Short % of float | 4.6% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).